Hemodynamic effects of TX45 , a long-acting Fc-relaxin fusion, in Group 2 pulmonary hypertension patients.

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease Haemodynamics of Heart Failure HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by